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Abstract 
Background Allergic diseases are the leading causes of chronic 
illness in children and young adults in the UK. 
Aim To undertake a comprehensive review of the evidence on 
the effect of breastfeeding (BF) duration and timing of solid 
food introduction (SFI), on the risk of wheeze, atopic dermatitis, 
rhino-conjunctivitis, food allergy, allergic sensitisation and measures 
of lung function or bronchial hyper-responsiveness. 
Methods We carried out a systematic review following the 
PRISMA guidelines (International Prospective Register of Systematic 
Reviews [PROSPERO] CRD42013003802). We included 
intervention, cohort, case-control and cross-sectional studies. 
Following literature searches (July 2013), study eligibility, data 
extraction and risk of bias assessments were conducted independently 
by two investigators. Random effects meta-analyses 
were used to pool results. Five levels of comparison of total or 
exclusive BF duration were used to assess disease risk in children 
at age 0–4 yrs, 5–15 yrs or 15+yrs: ‘never vs ever’,’_1–2 
months vs. <1–2 months’, ‘_3–4 months vs. <3–4 months’, 
‘_5–7 months vs. <5–7 months’, and ‘_8–12 months vs. <8– 
12 months’. Exclusive BF (EBF; BF without formula or solid 
food supplementation) was categorised as ‘_0–2 months vs. <0– 
2 months’, ‘_3–4 months vs. <3–4 months’ and ‘_5+ months 
vs. <5+ months’, and SFI as ‘_3–4 months vs. <3–4 months’. 
Publication bias was assessed using Egger’s asymmetry test. 
Results Of 16,289 identified studies, 564 met the inclusion criteria 
and were eligible for analysis. We found reduced risk of 
wheezing in children aged 5–14 yrs with longer BF or EBF duration, 
which was dose-dependent, but there was evidence of publication 
bias (BF and odds of recurrent wheezing P = 0.007). 
Similar results were found for recurrent wheeze at age 5–14 yrs 
but not in other ages. Measures of lung function were also 
increased with increased BF or EBF duration. We found no evidence that BF duration 
influences other allergic outcomes, 
and no evidence that timing of SFI influences any of the outcomes 
assessed. 
Conclusion Longer breastfeeding duration may protect against 
wheezing later in childhood. Any effect is likely to be through 
effects on lung function rather than allergic sensitisation. Other 
allergic outcomes do not appear to be influenced by breastfeeding duration  
 
